Cannara Biotech (8CB0) Stock Overview

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

8CB0 Stock Information

Symbol

8CB0

Address

333 Decarie Blvd.Saint-Laurent, QC H4N 3M9Canada

Founded

Trading hours

Website

https://cannara.ca

Country

🇨🇦 Canada

Phone Number

514-543-4200

Cannara Biotech (8CB0) Price Chart

Cannara Biotech Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.444592641991775	N/A
Market Cap	$39.70M	N/A
Shares Outstanding	89.30M	1.86%
Employees	461.00	N/A
Shareholder Equity	79.74M	19.49%

Valuation	2023	Change
P/E Ratio	5.56	N/A
P/S Ratio	0.94	N/A
P/B Ratio	0.50	N/A

Growth	2023	Change
Return on Equity	0.0640	N/A

Earnings	2023	Change
Revenue	$42.06M	N/A
Earnings	$5.10M	N/A
EPS	0.08	N/A
Earnings Yield	0.1799	N/A
Gross Margin	0.4756	N/A
Operating Margin	0.2099	N/A
Net income margin	0.1213	N/A

Financial Strength	2023	Change
Total Assets	$103.95M	N/A
Total Debt	$33.63M	N/A
Cash on Hand	$3.14M	N/A
Debt to Equity	0.5690	-12.20%
Cash to Debt	0.0933	-62.74%
Current Ratio	$2.44	-29.38%